CHLAMYDIA - ANVISA Registration 81816720067

Access comprehensive regulatory information for CHLAMYDIA in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81816720067 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until Sep 23, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG, VIRCELL S.L., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81816720067
2 Related Devices
Registration Details
ANVISA Registration Number: 81816720067
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

CHLAMYDIA TRACHOMATIS VIRCLIA® IgM MONOTEST
Risk Class IV

Registration Details

81816720067

25351637831202387

31167508000102

Company Information

Dates and Status

Sep 23, 2024

23/09/2034

09/18/2025 19:00:01

CHLAMYDIA TRACHOMATIS VIRCLIA® IgM MONOTEST
Risk Class IV

Registration Details

81816720067

25351637831202387

31167508000102

Dates and Status

Sep 23, 2024

23/09/2034

09/18/2025 19:00:01